Introduction Psoriasis management is challenging, especially in pediatric age for different
factors. The introduction of biologic drugs and oral small molecules (OSM) revolutionized the …

Introduction The management of moderate-to-severe forms of psoriasis is becoming a
frequent concern in geriatric age due to the higher risk to develop treatment adverse events …

Background Psoriasis is a chronic inflammatory disease with clinical manifestations of the
skin that affect adults and children. In adults, biologics have revolutionized the treatment of …

Psoriasis is a chronic systemic inflammatory disease that primarily affects the skin and is
associated with multiple comorbidities with a considerable reduction in quality of life of …

The emergence of data from clinical trials of biologics, the approval of new biologics, and
our improved understanding of psoriasis pathogenesis have increased the therapeutic …

Psoriasis is a chronic, immune-mediated, inflammatory skin disease, affecting 1–3% of the
white population. Although the existence of two psoriasis incidence peaks has been …

Psoriasis is a chronic inflammatory systemic disease primarily affecting the skin, but which
often involves considerable comorbidities as well. One-third of psoriasis cases start during …

The clinical presentation, disease associations, and diverse treatment modalities in
overcoming the challenges of managing pediatric psoriasis have been extensively …

Introduction Psoriasis prevalence in the elderly is growing. It is estimated that 15% of elderly
psoriasis patients suffer from moderate-to-severe disease, thus requiring systemic …

This article provides comprehensive recommendations for the systemic treatment of severe
pediatric psoriasis based on evidence obtained from a systematic review of the literature …